Related Experiment Video
Updated: Nov 22, 2025

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
MTORC1-Regulated Metabolism Controlled by TSC2 Limits Cardiac Reperfusion Injury
Christian U Oeing1,2, Seungho Jun2, Sumita Mishra2
1Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Berlin, Germany, and German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany (C.U.O.).
Rationale:
The mTORC1 (mechanistic target of rapamycin complex-1) controls metabolism and protein homeostasis and is activated following ischemia reperfusion (IR) injury and by ischemic preconditioning (IPC). However, studies vary as to whether this activation is beneficial or detrimental, and its influence on metabolism after IR is little reported. A limitation of prior investigations is their use of broad gain/loss of mTORC1 function, mostly applied before ischemic stress. This can be circumvented by regulating one serine (S1365) on TSC2 (tuberous sclerosis complex) to achieve bidirectional mTORC1 modulation but only with TCS2-regulated costimulation.
Objective:
We tested the hypothesis that reduced TSC2 S1365 phosphorylation protects the myocardium against IR and is required for IPC by amplifying mTORC1 activity to favor glycolytic metabolism.
Methods And Results:
Mice with either S1365A (TSC2SA; phospho-null) or S1365E (TSC2SE; phosphomimetic) knockin mutations were studied ex vivo and in vivo. In response to IR, hearts from TSC2SA mice had amplified mTORC1 activation and improved heart function compared with wild-type and TSC2SE hearts. The magnitude of protection matched IPC. IPC requited less S1365 phosphorylation, as TSC2SE hearts gained no benefit and failed to activate mTORC1 with IPC. IR metabolism was altered in TSC2SA, with increased mitochondrial oxygen consumption rate and glycolytic capacity (stressed/maximal extracellular acidification) after myocyte hypoxia-reperfusion. In whole heart, lactate increased and long-chain acylcarnitine levels declined during ischemia. The relative IR protection in TSC2SA was lost by lowering glucose in the perfusate by 36%. Adding fatty acid (palmitate) compensated for reduced glucose in wild type and TSC2SE but not TSC2SA which had the worst post-IR function under these conditions.
Conclusions:
TSC2-S1365 phosphorylation status regulates myocardial substrate utilization, and its decline activates mTORC1 biasing metabolism away from fatty acid oxidation to glycolysis to confer protection against IR. This pathway is also engaged and reduced TSC2 S1365 phosphorylation required for effective IPC. Graphic Abstract: A graphic abstract is available for this article.
Insights
Reduced TSC2 phosphorylation protects the heart from ischemia reperfusion injury by boosting mTORC1 activity and favoring glucose metabolism. This mechanism is crucial for ischemic preconditioning and myocardial protection.
Area of Science:
- Cardiovascular Biology
- Metabolic Regulation
- Cell Signaling
Background:
- The mechanistic target of rapamycin complex-1 (mTORC1) pathway is activated by ischemia reperfusion (IR) injury and ischemic preconditioning (IPC).
- The role of mTORC1 activation in IR injury remains controversial, with limited understanding of its metabolic impact.
- Prior studies used broad mTORC1 modulation, hindering specific mechanistic insights.
Purpose of the Study:
- To investigate the hypothesis that reduced TSC2 S1365 phosphorylation protects the myocardium against IR injury.
- To determine if this reduction is essential for IPC by enhancing mTORC1 activity and promoting glycolytic metabolism.
Main Methods:
- Utilized mice with S1365A (TSC2SA; phospho-null) and S1365E (TSC2SE; phosphomimetic) knockin mutations.
- Assessed ex vivo and in vivo heart function, mTORC1 activation, and metabolic profiles following IR.
- Manipulated perfusate glucose and fatty acid levels to evaluate substrate utilization.
Main Results:
- TSC2SA hearts exhibited amplified mTORC1 activation and improved function post-IR compared to wild-type and TSC2SE hearts.
- The protective effect in TSC2SA mice mimicked IPC, which also required reduced TSC2 S1365 phosphorylation.
- Metabolically, TSC2SA hearts showed increased mitochondrial respiration and glycolytic capacity, with altered substrate utilization favoring glycolysis over fatty acid oxidation.
Conclusions:
- TSC2-S1365 phosphorylation status critically regulates myocardial substrate utilization during IR.
- Declined TSC2-S1365 phosphorylation activates mTORC1, shifting metabolism towards glycolysis for IR protection.
- This pathway and reduced TSC2 S1365 phosphorylation are necessary for effective IPC.

